Rankings
▼
Calendar
KNSA Q4 2017 Earnings — Kiniksa Pharmaceuticals, Ltd. Revenue & Financial Results | Market Cap Arena
KNSA
Kiniksa Pharmaceuticals, Ltd.
$3B
Q4 2017 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$0
Gross Profit
$0
Operating Income
-$33M
Net Income
-$33M
EPS (Diluted)
$-1.01
QoQ Revenue Growth
NaN%
Cash Flow
Operating Cash Flow
-$23M
Free Cash Flow
-$23M
Stock-Based Comp.
$347,000
Balance Sheet
Total Assets
$47M
Total Liabilities
$137M
Stockholders' Equity
-$90M
Cash & Equivalents
$46M
← FY 2017
All Quarters
Q1 2018 →
